Immunocore Holdings plc Net Income (Loss) Attributable to Parent in USD from 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Immunocore Holdings plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to Q3 2025.
  • Immunocore Holdings plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$177K, a 102% decline year-over-year.
  • Immunocore Holdings plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$29.2M, a 37.9% increase year-over-year.
  • Immunocore Holdings plc annual Net Income (Loss) Attributable to Parent for 2024 was -$51.1M, a 7.6% increase from 2023.
  • Immunocore Holdings plc annual Net Income (Loss) Attributable to Parent for 2023 was -$55.3M, a 5.22% decline from 2022.
  • Immunocore Holdings plc annual Net Income (Loss) Attributable to Parent for 2022 was -$52.5M, a 70.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Immunocore Holdings plc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$29.2M -$177K -$8.91M -102% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$20.3M -$10.3M +$1.32M +11.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-06
Q1 2025 -$21.6M $5.02M +$29.5M Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-06
Q4 2024 -$51.1M -$23.8M -$4.04M -20.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 -$47M $8.74M +$7.83M +864% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$54.9M -$11.6M +$5.4M +31.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-06
Q1 2024 -$60.3M -$24.4M -$4.99M -25.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-06
Q4 2023 -$55.3M -$19.7M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 $906K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$17M Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$19.4M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06

Immunocore Holdings plc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$51.1M +$4.2M +7.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$55.3M -$2.74M -5.22% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$52.5M +$127M +70.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 -$180M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.